<\/span><\/h2>\n\n\n\nA SWOT Analysis helps researchers and entrepreneurs in understanding the health of a company. It explores and discusses four different elements in a square with four quadrants for each. The elements discussed in a SWOT Analysis are strengths, weaknesses, opportunities, and threats.<\/p>\n\n\n\n
A SWOT Table is to make the study easier and visually presentable by highlighting key aspects.<\/p>\n\n\n\n
Let us discuss the internal and external factors in detail through Johnson & Johnson SWOT Analysis before moving on to the SWOT Table for the company.<\/p>\n\n\n\n
<\/span>Johnson & Johnson\u00a0Internal Factors<\/span><\/h2>\n\n\n\nStrengths and weaknesses are considered internal strategic factors of a business that are in its control.<\/p>\n\n\n\n
<\/span>\ud83d\udcaa<\/strong><\/strong> Strengths<\/span><\/h3>\n\n\n\nAny comparative or competitive advantage Johnson & Johnson has over its competitors is known as its strength. In this section, we will take a hard look at all the strengths of the company.<\/p>\n\n\n
\n
![\"Through](\"https:\/\/essayzoo.org\/blog\/wp-content\/uploads\/2022\/05\/Johnson-Johnson-Strengths-1024x576.png\")
<\/figure><\/div>\n\n\n<\/span>Global Dominance<\/span><\/h4>\n\n\n\nThere is no question about the dominance of the pharmaceutical company in the global market. With over 250 brands under its belt and a distribution network spanning over 200 countries in its business operations, it is one of the most dominant global players in personal care and drugs, as well as medical devices.<\/p>\n\n\n\n
<\/span>Influence<\/span><\/h4>\n\n\n\nJohnson & Johnson is often considered to be the most influential company in the world for its pharmaceutical products. With many countries and small companies reliant on its wellbeing, it can even disturb the US stocks.<\/p>\n\n\n\n
<\/span>Experienced Player<\/span><\/h4>\n\n\n\nAnother point of strength that sets the company apart from its competitors is its immense experience and expertise in designing and producing consumer-centric products that drive worldwide sales.<\/p>\n\n\n\n
<\/span>Expansive Product Portfolio<\/span><\/h4>\n\n\n\nJohnson & Johnson prides itself in offering a wide range of pharmaceutical products to its clients. The product portfolio of the company ranges from baby products to antiseptics and beyond.<\/p>\n\n\n\n
<\/span>Social Initiatives & Engagements<\/span><\/h4>\n\n\n\nAs a major stakeholder in its market segment as well as a global citizen, the company engages in many social and industrial initiatives to make the world a better and safer place. Johnson & Johnson has collaborated with the UN and other organizations to bring awareness to the masses and the producers.<\/p>\n\n\n\n
<\/span>Excellent Supply Chain<\/span><\/h4>\n\n\n\nFrom procuring raw materials to supplying finished products to the retailers, distributors, and pharmacies, Johnson & Johnson has an excellent supply chain mechanism that ensures its exceptional sales.<\/p>\n\n\n\n
<\/span>Fruitful Partnerships<\/span><\/h4>\n\n\n\nThe company understands that instead of entering a new market and doing all the things on its own, it is best to get the already established brands and leading producers in partnerships to make new and exciting products.<\/p>\n\n\n\n
<\/span>Strategic Marketing Campaigns<\/span><\/h4>\n\n\n\nJohnson & Johnson’s products have managed to carve out a corner for trust and respect in its consumers. Its marketing is on point and targeted toward capturing the emotional essence of prospects and current consumers.<\/p>\n\n\n\n
<\/span>Mergers & Acquisitions<\/span><\/h4>\n\n\n\nIn recent times, the company has acquired and merged many profitable and leading market players from different segments, such as medical devices, under its umbrella. This allows the company to start reaping profits as soon as it is done with the paperwork.<\/p>\n\n\n\n
<\/span>\ud83e\udd12 Weaknesses<\/span><\/h3>\n\n\n\nThe flaws and drawbacks in a business model or the operations of Johnson & Johnson are known as its weaknesses.<\/p>\n\n\n
\n
![\"Bad](\"https:\/\/essayzoo.org\/blog\/wp-content\/uploads\/2022\/05\/Johnson-Johnson-Weaknesses-1024x576.png\")
<\/figure><\/div>\n\n\n<\/span>Lawsuits & Financial Setbacks<\/span><\/h4>\n\n\n\nThrough lawsuits, Johnson & Johnson has almost lost over $15 Billion, including many of its products, such as baby talcum powder Xarelto and op-addictive drug Norman.<\/p>\n\n\n\n
This also resulted in eroding consumer trust and respect for the company.<\/p>\n\n\n\n
<\/span>Poor Product Diversity<\/span><\/h4>\n\n\n\nOut of all the major brands that Johnson & Johnson controls, three divisions bring the most revenue and growth for the parent company. Due to the volatile nature of the US economy, the company can suffer both short and long-term cash flow problems.<\/p>\n\n\n\n
<\/span>Dependence on a Handful Brands & Products<\/span><\/h4>\n\n\n\nThe company depends on a handful of brands and products to bring in massive sales figures for medical devices. Yet, governments are loosening up regulations over competitive items with generic character. This allows other smaller players to carve out a bigger chunk of the market share.<\/p>\n\n\n\n
<\/span>Sluggish Decision Making<\/span><\/h4>\n\n\n\nAs a large corporation among the pharmaceutical companies, Johnson & Johnson suffers from too many moving parts and too many brands to consider resulting in slow and delayed decision making.<\/p>\n\n\n\n
<\/span>Controversial Production & Supply Channels<\/span><\/h4>\n\n\n\nJust like other big players in the market, Johnson & Johnson has often relied on controversial suppliers and channels to replenish its supply channels. This led to backlash from regulatory and activist bodies resulting in a poor brand image.<\/p>\n\n\n\n
<\/span>Poor Publicity\u00a0& Deteriorating Trust<\/span><\/h4>\n\n\n\nDue to the controversies and the company\u2019s nature as a large corporation in the pharmaceutical industry, Johnson & Johnson often ends up at the receiving end of negative publicity resulting in tainted trust.<\/p>\n\n\n\n
<\/span>Johnson & Johnson\u00a0External Factors<\/span><\/h2>\n\n\n\nBoth opportunities and threats are combined in the external factors of a business to either provide a window for growth or run risks to end up on the ground.<\/p>\n\n\n\n
<\/span>\ud83e\udd11<\/strong> Opportunities<\/span><\/h3>\n\n\n\nAny market potential or avenue to generate revenue or ensure sustainability with strategic planning is known as an opportunity for the company. The opportunities that are at the disposal of Johnson & Johnson are as follows.<\/p>\n\n\n
\n
![\"Redefining](\"https:\/\/essayzoo.org\/blog\/wp-content\/uploads\/2022\/05\/Johnson-Johnson-Opportunities-1024x576.png\")
<\/figure><\/div>\n\n\n<\/span>Redefining Portfolio<\/span><\/h4>\n\n\n\nBy redefining its portfolio and exerting focus on brands and products that bring in more revenue, Johnson & Johnson can improve not only its market reach but also its profitability.<\/p>\n\n\n\n
Pfizer consumer healthcare did the same, like other pharmaceutical companies, and witnessed immense growth.<\/p>\n\n\n\n
<\/span>Strategic Expansion through Acquisitions<\/span><\/h4>\n\n\n\nThrough acquisitions of innovative products, large players such as Johnson & Johnson can improve their sustainability and market reach by grabbing on to the small but effective players.<\/p>\n\n\n\n
<\/span>Capturing Emerging Markets<\/span><\/h4>\n\n\n\nAround 60% of the company\u2019s global pharmaceutical revenue comes from the US alone. Johnson & Johnson can suffer a lot if the US economy takes a hit, just like during the pandemic.<\/p>\n\n\n\n
By capturing and moving on to the emerging markets in the developing countries, the company can diversify its revenue streams and disperse dependence.<\/p>\n\n\n\n
<\/span>Value through Price Discrimination<\/span><\/h4>\n\n\n\nThe company can introduce value-based products and items in its business models that can cater to the needs of the clients who prefer more affordable and value-added options.<\/p>\n\n\n\n
<\/span>Loyalty Programs<\/span><\/h4>\n\n\n\nThrough loyalty programs, Johnson & Johnson can retain a larger base of clients and customers who would feel that their needs are met with care and attention.<\/p>\n\n\n\n
<\/span>\ud83d\ude28 Threats<\/span><\/h3>\n\n\n\nThose external strategic factors that seriously dismantle a company\u2019s structure or its operations are threats. In the case of Johnson & Johnson, the risks and potential threats in this competitive environment are as follows.<\/p>\n\n\n
\n
![\"With](\"https:\/\/essayzoo.org\/blog\/wp-content\/uploads\/2022\/05\/Johnson-Johnson-Threats-1024x576.png\")
<\/figure><\/div>\n\n\n<\/span>Cut-Throat Competition<\/span><\/h4>\n\n\n\nJohnson & Johnson is not the only player in this market segment. Other players such as P&G, Unilever, and Reckitt Benckiser are catching up with the competition. If the condition persists, Johnson & Johnson can end up losing a large chunk of its earnings.<\/p>\n\n\n\n
<\/span>Proliferation of Generics<\/span><\/h4>\n\n\n\nRecently, the generic alternatives of Zytiga were allowed to be sold in the market. If this precedent is set and other generics end up in the pharmaceutical sector in the future, the company can end up with lost revenue in the consumer health care division.<\/p>\n\n\n\n
<\/span>Stiff Regulations<\/span><\/h4>\n\n\n\nWith a global footprint in over 200 countries, the company needs to comply with all the different countries with varying, sometimes hostile regulations structures. This results in poor company growth and revenue generation.<\/p>\n\n\n\n
<\/span>Technologically-Improved Substitutes<\/span><\/h4>\n\n\n\nSubstitutes for all drugs and products are on the rise. There are many start-ups and emerging players who are determined to introduce cheaper substitutes. If this happens in the future, the company will lose major growth potential and revenue stream.<\/p>\n\n\n\n
<\/span>Campaigning Against Drug Abuse<\/span><\/h4>\n\n\n\nThe US has faced immense phases of opioid-based addiction and drug abuse. Now, the government and the public are wary of companies like Johnson & Johnson.<\/p>\n\n\n\n
If the regulations start to get stricter, the company would not only lose its profitability but also needs to grab on to survival measures to stay afloat.<\/p>\n\n\n\n
<\/span>Johnson & Johnson SWOT Table<\/span><\/h2>\n\n\n\n
![\"Johnson](\"https:\/\/essayzoo.org\/blog\/wp-content\/uploads\/2022\/05\/Johnson-and-Johnson-SWOT-Analysis-Chart.png\")
<\/figure><\/div>\n\n\n<\/span>Strengths<\/span><\/h3>\n\n\n\n\n- \ud83d\udcaa Global Dominance<\/li>\n\n\n\n
- \ud83d\udcaa Influence<\/li>\n\n\n\n
- \ud83d\udcaa Experienced Player<\/li>\n\n\n\n
- \ud83d\udcaa Expansive Product Portfolio<\/li>\n\n\n\n
- \ud83d\udcaa Social Initiatives & Engagements<\/li>\n\n\n\n
- \ud83d\udcaa Excellent Supply Chain<\/li>\n\n\n\n
- \ud83d\udcaa Fruitful Partnerships<\/li>\n\n\n\n
- \ud83d\udcaa Strategic Marketing Campaigns<\/li>\n\n\n\n
- \ud83d\udcaa Mergers & Acquisitions<\/li>\n<\/ul>\n\n\n\n
<\/span>Weaknesses<\/span><\/h3>\n\n\n\n\n- \ud83e\udd12 Lawsuits & Financial Setbacks<\/li>\n\n\n\n
- \ud83e\udd12 Poor Product Diversity<\/li>\n\n\n\n
- \ud83e\udd12 Dependence on a Handful Brands & Products<\/li>\n\n\n\n
- \ud83e\udd12 Sluggish Decision Making<\/li>\n\n\n\n
- \ud83e\udd12 Controversial Production & Supply Channels<\/li>\n\n\n\n
- \ud83e\udd12 Poor Publicity & Deteriorating Trust<\/li>\n<\/ul>\n\n\n\n